ADMA | ADMA Biologics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	18.95 - 19.55
52 Week Range	3.54 - 21.13
Beta	0.81
Implied Volatility	85.79%
IV Rank	24.62%
Day's Volume	4,426,512
Average Volume	5,315,896
Shares Outstanding	233,083,000
Market Cap	4,454,216,130
Sector	Healthcare
Industry	Biotechnology
IPO Date	2013-10-17

Valuation
Profitability
Growth
Health
P/E Ratio	136.50
Forward P/E Ratio	N/A
EPS	0.14
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	624
Country	USA
Website	ADMA

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

ADMA's peers: ABUS, ATRA, FATE, SANA, CRBU, RCUS, TFFP, INMB, ANEB, ABCM, ANTX, ETNB, MDGL, PLRX, ACLX, STOK, PLX, CDTX, AKBA, XFOR, MCRB, VXRT, IBIO, TNXP, BCRX

*Chart delayed

Analyzing fundamentals for ADMA we got that it has average fundamentals where Valuation is considered to be overvalued, Profitability is moderate, Growth is good and Health is strong. For more detailed analysis please see ADMA Fundamentals page.

Watching at ADMA technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ADMA Technicals page.